\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ focal\\ deficits\\.\\ \\ mild\\ mental\\ retardation\ \(0\)\
\-\ resumption\\ of\\ proper\\ diet\\ and\\ tetrahydrobiopterin\\ therapy\ \(0\)\
\-\ abnormal\\ periventricular\\ and\\ deep\\ white\\ matter\\ lesions\\.\ \(0\)\
\-\ phenylketonuria\ \(1\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ lyme\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ adem\ \(0\)\
\-\ \\â\\€\\¢\\ leukoencephalopathy\\ nos\ \(0\)\
\-\ 19\\ year\\ old\\ woman\\ diagnosed\\ with\\ pku\\ \\(phenylketonuria\\)\\ by\\ newborn\\ testing\\.\\ \\ she\\ has\\ recently\\ \\(about\\ a\\ year\\)\\ not\\ followed\\ appropriate\\ diet\\ restrictions\\.\\ \\ she\\ now\\ presents\\ with\\ seizures\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ phenylketonuria\\:\\ 0\\.2592799536460735\ \(0\)\
\-\ diet\\:\\ 0\\.15388233780912908\ \(0\)\
\-\ resumption\\:\\ 0\\.12963997682303674\ \(0\)\
\-\ tetrahydrobiopterin\\:\\ 0\\.12963997682303674\ \(0\)\
\-\ pku\\:\\ 0\\.12963997682303674\ \(0\)\
\-\ nos\\:\\ 0\\.10925329504186188\ \(0\)\
\-\ restrictions\\:\\ 0\\.09905995415127444\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0921773147997581\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.08713450979515197\ \(0\)\
\-\ retardation\\:\\ 0\\.0848675880329864\ \(0\)\
\-\ lyme\\:\\ 0\\.07778173381397555\ \(0\)\
\-\ proper\\:\\ 0\\.07735544650701595\ \(0\)\
\-\ adem\\:\\ 0\\.07576407026230665\ \(0\)\
\-\ periventricular\\:\\ 0\\.07240732538023341\ \(0\)\
\-\ she\\:\\ 0\\.07055253357218154\ \(0\)\
\-\ newborn\\:\\ 0\\.06847993147951215\ \(0\)\
\-\ testing\\:\\ 0\\.060785105835915856\ \(0\)\
\-\ appropriate\\:\\ 0\\.05923568648800665\ \(0\)\
\-\ mental\\:\\ 0\\.05863536303917937\ \(0\)\
\-\ recently\\:\\ 0\\.05863536303917937\ \(0\)\
\-\ 19\\:\\ 0\\.05794589854066686\ \(0\)\
\-\ deficits\\:\\ 0\\.0575035830224716\ \(0\)\
\-\ seizures\\:\\ 0\\.0540272774627035\ \(0\)\
\-\ deep\\:\\ 0\\.05086664925433067\ \(0\)\
\-\ matter\\:\\ 0\\.04947764662354114\ \(0\)\
\-\ about\\:\\ 0\\.04844202214859194\ \(0\)\
\-\ diagnosed\\:\\ 0\\.046208752305808905\ \(0\)\
\-\ sclerosis\\:\\ 0\\.045136988726858014\ \(0\)\
\-\ now\\:\\ 0\\.042957582201494815\ \(0\)\
\-\ followed\\:\\ 0\\.04213052752027605\ \(0\)\
\-\ white\\:\\ 0\\.04167800312811791\ \(0\)\
\-\ focal\\:\\ 0\\.035889611825564736\ \(0\)\
\-\ abnormal\\:\\ 0\\.03583959176933693\ \(0\)\
\-\ lesions\\:\\ 0\\.03364059568152864\ \(0\)\
\-\ therapy\\:\\ 0\\.03359765876824431\ \(0\)\
\-\ mild\\:\\ 0\\.033091962557810835\ \(0\)\
\-\ woman\\:\\ 0\\.02902798452189568\ \(0\)\
\-\ year\\:\\ 0\\.028120743213909255\ \(0\)\
\-\ multiple\\:\\ 0\\.026467735345283367\ \(0\)\
\-\ presents\\:\\ 0\\.02567123963982244\ \(0\)\
\-\ has\\:\\ 0\\.02359852897785703\ \(0\)\
\-\ \\(\\:\\ 0\\.021245933124819427\ \(0\)\
\-\ \\)\\:\\ 0\\.020986402709214855\ \(0\)\
\-\ by\\:\\ 0\\.020924572106542274\ \(0\)\
\-\ disease\\:\\ 0\\.020540257959054474\ \(0\)\
\-\ not\\:\\ 0\\.018159098113851992\ \(0\)\
\-\ old\\:\\ 0\\.012866685247974333\ \(0\)\
\-\ no\\:\\ 0\\.0126535904515265\ \(0\)\
\-\ a\\:\\ 0\\.0058323500267441365\ \(0\)\
\-\ and\\:\\ 0\\.0052943825215358365\ \(0\)\
\-\ with\\:\\ 0\\.0034412992967614627\ \(0\)\
\-\ \\.\\:\\ 0\\.0026102600071578144\ \(0\)\
\-\ of\\:\\ 0\\.0017132911882057121\ \(0\)\
